Everolimus (EVE) for relapsed/refractory classical Hodgkin lymphoma (cHL): Open-label, single-arm, phase II study.
Patrick B. Johnston
Consultant or Advisory Role - Novartis (U)
Lauren C. Pinter-Brown
No relevant relationships to disclose
Jaqueline Willemann Rogerio
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Ghulam Warsi
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Quincy Chau
No relevant relationships to disclose
Rod Ramchandren
Honoraria - Seattle Genetics